Latest Diabetes: Type II news
Risk for Foot Disease Modestly Lower With SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists in T2DM
posted January 6th
by modernClinician Editorial Team
by modernClinician Editorial Team
Incretin Receptor Agonists Tied to Better Outcomes in Adults With Obesity, T2DM, Obstructive Sleep Apnea
posted January 5th
by modernClinician Editorial Team
by modernClinician Editorial Team
Statin Initiation Beneficial in T2DM, Regardless of Cardiovascular Risk
posted January 5th
by modernClinician Editorial Team
by modernClinician Editorial Team
GLP-1 Receptor Agonist Use May Lower Vertebral Fracture Risk With Type 2 Diabetes
posted December 17th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
NOACs Linked to Slower Cognitive Decline in Patients With A-Fib, Alzheimer Disease 
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes 
Type 2 Diabetes Linked to Worse Menopausal Symptoms 
Add-On Tirzepatide May Reduce MACE Risk in People With T2D, ASCVD Related Articles
.jpg)
Semaglutide Not Linked to Higher Neovascular Age-Related Macular Degeneration Risk 
AHA: Consuming Up to 400 mg/Day of Caffeine Safe for Most Adults 
GLP-1 Receptor Agonist Use Linked to Higher Risk for Ischemic Optic Neuropathy Monthly Specialist Briefings
Stay Connected
